Commercial Determinants of Noncommunicable Diseases in the WHO European Region: A Summary Key Takeaways Noncommunicable diseases (NCDs) account for 90% of deaths in the WHO European Region, with commercial determinants
Author: Cody Micah Carmichael MPH, CPH
Top 5 Takeaways Heavy Metal Poisonings: Investigations in Rhode Island and Missouri during 2018-2019 linked heavy metal poisonings to cakes decorated with luster dust containing high levels of copper, lead,
Top 5 Takeaways Decline in Global Vaccination Coverage: In 2020, global coverage for DTP3 and Pol3 decreased to 83%, and MCV1 coverage decreased to 84%, marking a drop from 2019
Epi Explained: What are Epi Curves? An Epidemic Curve, commonly referred to as an epi curve, is a visual tool used in epidemiology to represent the onset and progression of
Evidence-Based Approaches to Public Health: Epidemiology – Study Designs: Experimental Studies (Community Trials) In this tutorial, we will cover community trials, a type of experimental study design used in public
Top 5 Takeaways Lower Vaccine Effectiveness: The effectiveness of mRNA vaccines against COVID-19-associated hospitalization was lower among immunocompromised adults (77%) compared to immunocompetent adults (90%). Variation Among Subgroups: Vaccine effectiveness
Top 5 Takeaways Additional Primary Dose for Immunocompromised: ACIP recommends an additional mRNA COVID-19 vaccine dose for moderately to severely immunocompromised individuals. Booster Dose Recommendations: ACIP recommends a COVID-19 vaccine
COVID-19 Vaccination Significantly Reduces Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) in California Key Takeaways Vaccinated children in California had a notably lower risk of developing MIS-C, a rare
Evidence-Based Approaches to Public Health: Epidemiology – Study Designs: Experimental Studies (Randomized Controlled Trials) In this tutorial, we will explore randomized controlled trials (RCTs), a key type of experimental study
Top 5 Takeaways Higher Odds of COVID-19 in Previously Infected: Unvaccinated adults with previous SARS-CoV-2 infection had 5.49 times higher odds of laboratory-confirmed COVID-19 compared to fully vaccinated individuals without